Search Results for: IONIS-HTTRx

IONIS-HTTRx

IONIS-HTTRx, also called RG6042, is a potential treatment for Huntington’s disease developed by Ionis Pharmaceuticals. Ionis licensed IONIS-HTTRx to Roche in late 2017, making Roche responsible for the further development and ... Read more